FROM THE MEDICAL MONITOR’S DESK
Perspectives from inside oncology clinical development.
Practical insights on medical monitoring, patient safety, trial execution, and the decisions that shape early oncology development.
The Hidden Operational Complexity Behind Precision Oncology
Precision oncology may look elegantly targeted from the outside, but delivering it inside a clinical trial requires coordination across testing, data, timing, sites, patients, and specialized teams.
Biomarkers in Oncology Trials: What They Promise and What They Quietly Complicate
Biomarkers can make oncology trials more precise, but that precision introduces new dependencies and gray areas. Assays, thresholds, timing, and eligibility decisions can quietly reshape a study.